U.S. Biotech Stock News

With major US indexes recently lifted by upbeat earnings from companies like Boeing, Ford, PayPal, and Coca-Cola, and chip stocks under pressure from fresh questions around AI funding deals and Chinese competition, stock selection matters more than ever. This Earnings Momentum Stocks screener focuses on larger companies that currently show moderate risk profiles and positive signals on both recent value gains and analyst outlooks. In this article you will see three stocks that appear...

Belden stock has delivered a strong 116.0% return over the past five years, yet recent weakness and a mixed valuation score raise questions about how much upside is left at around US$104.93. Over five years Belden has returned 116.0%, which puts the recent share price pullback into context as part of a much longer positive run. Future revenue and cash flow expectations can support the current valuation, while any pressure on profitability or larger investment needs may weigh on what...

Recent trading snapshot for Alamo Group stock Alamo Group (ALG) recently closed at US$164.24, with the stock showing mixed performance over different periods. The share price is down about 3% over the past month and roughly 2% over the past 3 months. See our latest analysis for Alamo Group. Over a longer stretch, Alamo Group’s share price return is down year to date, while the 1 year total shareholder return has declined more sharply. This suggests that the recent positive 7 day share price...

In May 2026, Medtronic initiated a voluntary Class II recall of specific lots of its DLP One-Piece Pediatric Arterial Cannula after reports of loose foreign material containing trace blood, with the action now ongoing and affecting worldwide distribution including several US states. At the same time, Medtronic has been reshaping its portfolio with the US$650 million SPR Therapeutics acquisition and ViaVerte pain system launch, adding non-opioid therapies alongside near-term quality and...

Renasant (RNST) is in focus after reporting second quarter 2026 results, with higher net interest income and net income compared with a year ago, alongside lower net loan charge offs. See our latest analysis for Renasant. Renasant’s second quarter update comes after a strong share price run, with a 24.09% year to date share price return and a 55.62% total shareholder return over three years, which suggests momentum has been building into these results. If this kind of progress has your...

Oil and gas stocks are back in the spotlight as conflict between the U.S. and Iran disrupts supply routes and lifts fuel costs. With the Strait of Hormuz closed and consumers facing higher prices at the pump and the supermarket, energy producers sit at the center of this shock. Some companies could benefit from higher selling prices, while others face higher costs, policy risk, or demand pressure. This article walks through 3 large, financially stable oil and gas stocks that are closely...

After a very strong 5 year run, with Scorpio Tankers up about 450%, the stock now sits in a zone where its market price and intrinsic value estimate look broadly aligned rather than clearly cheap or expensive. The 5 year total return of roughly 450% puts Scorpio Tankers among the stronger performers in the sector, which naturally raises the bar for what counts as good value today. The recent move to replace higher coupon unsecured notes with a lower cost, asset backed credit facility can...

Estée Lauder Companies (EL) is back in the spotlight after unveiling Glimmer, a new prestige fragrance aimed at a new generation of consumers and featuring Hailee Steinfeld as the face of a global campaign. See our latest analysis for Estée Lauder Companies. Estée Lauder Companies’ Glimmer launch and recent board changes come as the stock shows short term momentum, with a 90 day share price return of 11.97%, but longer term total shareholder returns over one, three and five years still...

Happen stock edged up 1.1% to US$18.95 into the close, a modest move for a quarter that put earnings power firmly in the spotlight. Traders saw a routine beat. Long term investors saw something different. Diluted EPS hit about US$0.50 for Q2, with return on tangible common equity near 15.9%, and management raised full year EPS guidance to a higher range. The near term chart still shows a decline over the past month, which keeps shorter term holders cautious. The key question now is whether...

Wayfair (W) shares have been in focus after the company reported first quarter revenue growth of 7.4% year on year, ahead of analyst expectations, and a 5.2% Adjusted EBITDA margin, which marked its strongest first quarter profitability in five years. See our latest analysis for Wayfair. Wayfair's recent earnings release and the 11.5% 7 day share price return sit within a mixed picture. The stock has a 90 day share price return of 29%, while the year to date share price return is down 11.3%,...

Polaris stock came into this earnings print after a soft stretch, with the shares down over the past month and giving up another 4.2% today to close at US$71.59. That move suggests investors saw a problem. The headline numbers tell a different story. Q2 2026 flipped back to profit with basic earnings per share of US$1.85 on revenue of US$2,039.6m, after a loss in Q1. Management also raised full year guidance, which puts the focus squarely on whether this profit rebuild is durable or just a...

Marriott International stock has delivered a strong 5 year run, yet current valuation checks suggest the shares are trading at a premium to an intrinsic value estimate and to market based multiples. Marriott International has returned 179.9% over the past 5 years, which puts extra attention on whether the current share price still reflects a reasonable pay off for that performance. Recent expansion moves into all inclusive resorts and branded apartments may support long term cash flow...

In the second quarter of 2026, American Airlines Group Inc. reported record revenue of US$16,735 million but saw net income fall to US$71 million from US$599 million a year earlier, while also issuing guidance that third-quarter 2026 revenue would grow 16% to 19% year over year and unit revenue would improve versus the second quarter. Despite lowering its full-year earnings outlook amid sharply higher fuel costs, American Airlines highlighted growing premium and loyalty revenues and added...

Shares of Baxter International (BAX) moved higher in the latest session after TD Cowen lifted its valuation outlook on the stock while keeping a neutral rating, drawing fresh attention to the healthcare supplier. See our latest analysis for Baxter International. The TD Cowen revision comes after a strong run in Baxter International's share price, with a 90 day share price return of 44.20% and a year to date share price return of 24.97%. However, the 1 year total shareholder return has...

Amgen stock has delivered an 88.5% total return over the past five years, and the latest Discounted Cash Flow (DCF) estimate currently points to the shares trading at a 43.0% discount to intrinsic value, while broader valuation checks paint a more mixed picture. Over five years, Amgen has returned 88.5%, which puts current investors in a strong position and raises the question of how much of the story is already reflected in the share price. Management confidence around a broad portfolio of...

On July 14, 2026, C3.ai, Inc. reported that a U.S. federal court dismissed in full a putative securities class action lawsuit filed against the company and certain officers in August 2025, removing all asserted causes of action. This legal outcome lifts a significant source of uncertainty around potential litigation exposure and compliance concerns that had been hanging over C3.ai’s operations and governance. With the securities lawsuit dismissed, we’ll examine how reduced legal overhang...

FDA has approved Freenome's SimpleScreen blood-based colorectal cancer test for average-risk adults. Abbott Laboratories, NYSE:ABT, holds exclusive rights to commercialize SimpleScreen in the U.S. This agreement expands Abbott's colorectal cancer screening portfolio and strengthens its role in blood-based diagnostics. Abbott Laboratories, NYSE:ABT, is moving into a higher profile position in colorectal cancer screening through this new U.S. commercialization partnership for SimpleScreen...

Dolby Laboratories stock has had a tough run over the past few years, yet the valuation checks currently lean cheap and suggest the market may be pricing the business more pessimistically than those checks imply. Over the last 5 years, shareholders have seen the stock decline 43.1%, which points to a long stretch of weak returns that may already reflect a lot of caution. Future demand for Dolby Laboratories' audio and imaging technologies can support the case for the current price, while any...

The US Bureau of Economic Analysis is about to tweak how it measures the Fed’s preferred inflation gauge, the PCE index, and that could subtly shift how markets think about interest rates. A small downward adjustment to recent inflation readings may ease some pressure on future rate hikes, which often matters for growth oriented technology stocks with long term earnings stories. At the same time, debate around the timing and transparency of the change may keep volatility alive. This article...

Boeing stock jumped 4.8% to US$221.56 today, even as the headline print was another quarterly loss. The market cheered the cash story instead of the earnings line. Revenue for the second quarter came in at US$24.6b and free cash flow turned positive at US$631m, which matters far more for a heavily indebted manufacturer than a single quarter of earnings per share. Short term traders are reacting to relief. Long term investors will be weighing that fresh cash generation against a still heavy...

Cheniere Energy stock has delivered a very strong 207.0% return over the past 5 years, yet its low value score and broadly about-right market pricing raise questions about how much upside may still be left in the current valuation. Over 5 years, Cheniere Energy has returned 207.0%. This puts recent gains front and center when judging whether the current share price leaves much margin for error. Management focus on long term growth and shareholder value, set against the reality of global LNG...

Skyworks Solutions (NasdaqGS:SWKS) has suspended its dividend following weaker quarterly results. The company has authorized a new share repurchase program of up to US$2b. These moves mark a shift in how Skyworks is prioritizing cash returns to shareholders. Skyworks Solutions supplies analog and mixed signal semiconductors that sit inside smartphones, connected devices and a range of radio frequency applications. The company operates in markets tied to wireless connectivity and data usage,...

Tenable Holdings (NasdaqGS:TENB) has launched an always-on autonomous agentic fleet for its Hexa AI engine. The new capability supports continuous, automated exposure remediation and security operations within the Tenable One platform. The update represents a shift toward more autonomous security operations for Tenable customers. Tenable Holdings operates in a crowded cybersecurity field where enterprises are trying to manage rising volumes of vulnerabilities, alerts and compliance demands...

With inflation signals mixed, rates under review and energy prices tied to geopolitical risk, many investors are unsure where to look next for potential growth. The High-Quality Undiscovered Gems screener focuses on smaller stocks with strong fundamentals that large institutions may be overlooking. That can help you focus on business quality instead of short term macro headlines. In this article you will see 3 of the stocks from this screener, along with plain English explanations of what...